Manipal Health Enterprises earnings calls.

Manipal Health Enterprises delivered a strong Q1 FY27 with revenue of Rs 391 crore growing 38Current reported value: 38. No comparable prior figure is available in the source record.% YoY, driven by robust volume expansion—IP volumes surged 39%Current 39%. Reported change: +39% YoY. and OP volumes 26% YoY. Network EBITDA reached Rs 749Current reported value: 749. No comparable prior figure is available in the source record. crore (26% growth, or 30% excluding one-off), with margin expansion of 290bps to 24.2%. The company achieved industry-leading ALOS of 2.7 days and raised ARPO to Rs 77,200/day (+9% YoY) excluding Siadri. Key growth drivers include high-acuity Centers of Excellence now comprising 65%Current 65%. Reported change: +290bps YoY. of revenue (growing 45%), and digital revenue contributing Rs 710 croreCurrent Rs 710 crore. Reported change: 23% of Revenue. (23% of out-of-hospital earnings). Siadri integration is progressing—EBITDA margin reached 17.5% with 13% revenue growth. The 50th hospital launched in Electronic City, Bangalore with 300 beds, and Kinder Hospital acquisition announced. Capex guidance of Rs 2,000 crore for FY27 with Rs 900 crore already deployed in Q1. Post-IPO debt repayment, net debt/EBITDA will reduce to 0.9x. Key risks include slower-than-expected Siadri margin convergence, government scheme transition in East, and greenfield ramp-up costs. Management expressed confidence in sustaining volume-driven growth trajectory.